subperiosteal implants
The Mandibular Subperiosteal Implant Denture: A Prospective Survival Study
- 18 April 1994
- Posted by: anjaform
- Category: Clinical Studies and Case Reports
T. Yanase, R. L. Bodine, J. F. Tom, S. N. White
Full text link: https://pubmed.ncbi.nlm.nih.gov/8196000/
The Mandibular Subperiosteal Implant Denture: A Prospective Survival Study
1. Scientific Reference
- Study title: The mandibular subperiosteal implant denture: a prospective survival study
- Authors: R. T. Yanase, R. L. Bodine, J. F. Tom, S. N. White
- Scientific journal: Not specified in the information provided.
- Year of publication: 1994
- PMID: 8196000
- DOI: 10.1016/0022-3913(94)90096-5
2. Scientific Background
This study addresses the long-term performance of mandibular subperiosteal implants used to support prosthetic rehabilitation. Its particular scientific value lies in the extended observation period, with follow-up reaching as long as 21 years. Such longitudinal data provide insight into implant survival beyond the early and intermediate phases of treatment.
The clinical context is also important. According to the information provided, subperiosteal implant therapy was used in patients for whom conventional dentures could not otherwise provide usable function. The study therefore examines a treatment intended to address a challenging prosthetic situation while simultaneously documenting its long-term durability.
From an implant dentistry perspective, the investigation highlights the distinction between achieving prosthetic function and maintaining an implant-supported rehabilitation over many years. Long-term survival is consequently central to understanding the clinical performance of this treatment approach.
3. Study Objective
The study aimed to prospectively assess the long-term outcome of mandibular subperiosteal implants placed at the University of Southern California Advanced Prosthodontic Clinic.
The investigators documented implant follow-up over periods extending to 21 years, including maintenance and the management of complications. Survival over time represented a major component of the evaluation. No additional secondary objectives are specified in the abstract provided.
4. Methodology
This was a prospective survival study involving 81 mandibular subperiosteal implants placed at the University of Southern California Advanced Prosthodontic Clinic.
Patients were followed for varying periods, with the longest observation extending to 21 years. Follow-up, maintenance, and treatment related to complications were recorded throughout the study period.
Few patients were reported as lost to follow-up. However, the investigators noted that a significant number of patients died before completion of the study, reducing the population available for longer-term survival analyses.
The information provided does not specify the exact definition of implant survival or failure, detailed patient characteristics, surgical and prosthetic protocols, or the specific nature and frequency of the complications encountered.
5. Main Results
The study demonstrated a progressive reduction in the survival of mandibular subperiosteal implants as the duration of follow-up increased.
At 10 years, the calculated survival rate was 79%, based on 63 patients. At 15 years, survival had decreased to 60%, with this analysis based on 34 patients.
Beyond these numerical outcomes, the temporal pattern of implant loss is clinically relevant. Implant losses continued to accumulate during extended follow-up, and the available results did not indicate that this process reached a stable plateau.
The investigators therefore characterized the long-term survival of subperiosteal implants as low. Nevertheless, this finding needs to be considered alongside the functional outcome reported in the study: the treatment provided function for patients who otherwise could not use dentures. The study consequently documents both a functional contribution and important limitations in long-term implant survival.
6. Clinical Analysis
The principal clinical message of this study emerges from the evolution of survival over time rather than from a single survival percentage. An implant-supported rehabilitation may remain functional for a substantial period while continuing to accumulate failures during longer follow-up. In this cohort, the difference between the reported 79% survival at 10 years and 60% at 15 years illustrates why the duration of observation is critical when assessing implant longevity.
Equally important is the finding that implant loss did not appear to stabilize during the observation period. This suggests that long-term evaluation provides information that may not be apparent from shorter follow-up intervals.
The functional dimension of treatment should nevertheless remain part of the interpretation. According to the study, subperiosteal implant therapy enabled prosthetic function in patients who otherwise could not use dentures. Functional benefit and long-term implant survival, however, represent different clinical outcomes. Evidence of restored function should therefore not be interpreted as evidence of high long-term treatment survival.
The available abstract also provides no direct comparison with alternative implant or prosthetic approaches. Consequently, these findings cannot establish superiority, equivalence, or preferential indications relative to other rehabilitation strategies.
7. Clinical Applications
The findings are primarily relevant to the long-term assessment of mandibular prosthetic rehabilitation supported by subperiosteal implants, particularly in patients who were unable to function with dentures through other means described in the study.
From a broader clinical perspective, the data emphasize the importance of considering long-term survival when evaluating an implant-supported treatment. Initial or intermediate functional success does not necessarily predict comparable durability over substantially longer observation periods.
The information provided does not establish specific anatomical indications for subperiosteal implants or allow direct comparisons with bone grafting, other dental implant designs, or contemporary implant rehabilitation protocols. Such applications should therefore not be inferred from this study alone.
8. Level of Evidence, Limitations, and Transparency
The publication is described as a prospective survival study, providing longitudinal clinical observations over a period extending to 21 years. Based on the available information, it was not a randomized or controlled clinical trial.
Interpretation of the longer-term survival estimates should account for changes in the population remaining under observation. Although few patients were lost to follow-up, a significant number died before the study ended. The reported 10-year and 15-year survival estimates were consequently based on 63 and 34 patients, respectively.
Additional methodological limitations are not detailed in the abstract provided. In particular, the available information does not describe a control group or provide sufficient methodological detail for broader comparative conclusions.
No conflicts of interest or manufacturer-related affiliations are reported in the information provided.
9. Key Study Points
- Study design: Prospective survival study.
- Level of evidence: Prospective longitudinal clinical evidence; exact evidence level not specified in the information provided.
- Study population: Patients treated at the University of Southern California Advanced Prosthodontic Clinic.
- Number of patients or implants: 81 mandibular subperiosteal implants; exact initial number of patients not specified in the information provided.
- Follow-up duration: Up to 21 years.
- Main outcome assessed: Long-term survival of mandibular subperiosteal implants, with documentation of follow-up, maintenance, and treatment of complications.
- Main result: 79% survival at 10 years among 63 patients and 60% survival at 15 years among 34 patients.
- Scientific conclusion: Long-term survival was considered low, with implant loss continuing over time without an observed steady state.
- Potential limitations: Decreasing numbers of patients available for long-term assessment, partly because of patient deaths; additional methodological limitations are not detailed in the information provided.
10. Scientific Impact
A major contribution of this study is the length of its clinical observation. Follow-up extending to 21 years provides an opportunity to examine changes in implant survival that might be less apparent in studies restricted to shorter observation periods.
The results are particularly informative because survival continued to decline between the reported 10- and 15-year assessments. The absence of an apparent stabilization in implant loss further reinforces the importance of prolonged surveillance when evaluating the durability of an implant rehabilitation strategy.
The study also documents an important clinical distinction. Subperiosteal implants provided prosthetic function for patients who otherwise could not use dentures, yet their long-term survival remained limited. This combination of findings illustrates why functional rehabilitation and implant longevity should be evaluated as related but separate outcomes.
The study therefore contributes valuable longitudinal evidence concerning the long-term performance and limitations of mandibular subperiosteal implant rehabilitation.
11. Editorial Conclusion
This prospective study provides unusually long-term observations of mandibular subperiosteal implant rehabilitation. Survival decreased from 79% at 10 years to 60% at 15 years, while implant losses continued without an observed plateau. At the same time, treatment provided function for patients who otherwise could not use dentures. The findings therefore document both the functional value achieved in this patient population and the limitations of long-term implant survival, emphasizing the importance of extended follow-up when assessing the durability of implant-supported rehabilitation.
